Your browser doesn't support javascript.
loading
Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.
Gazda, Lawrence S; Martis, Prithy C; Laramore, Melissa A; Bautista, Melissa A; Dudley, Atira; Vinerean, Horatiu V; Smith, Barry H.
Affiliation
  • Gazda LS; The Rogosin Institute; New York, NY USA; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Martis PC; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Laramore MA; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Bautista MA; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Dudley A; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Vinerean HV; The Rogosin Institute-Xenia Division; Xenia, OH USA.
  • Smith BH; The Rogosin Institute; New York, NY USA; Department of Surgery; Weill Medical College of Cornell University; New York, NY USA; NewYork-Presbyterian Hospital; New York, NY USA.
Cancer Biol Ther ; 14(12): 1147-57, 2013 Dec.
Article in En | MEDLINE | ID: mdl-24025409
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepharose / Neoplastic Stem Cells / Carcinoma, Renal Cell / Taxoids / Octamer Transcription Factor-3 / Kidney Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepharose / Neoplastic Stem Cells / Carcinoma, Renal Cell / Taxoids / Octamer Transcription Factor-3 / Kidney Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2013 Type: Article